Supernus Pharmaceuticals, Inc. (SUPN) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Supernus Pharmaceuticals, Inc. (SUPN) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $2.98B, listed on NASDAQ, employing roughly 674 people, carrying a beta of 0.57 to the broader market. Supernus Pharmaceuticals, Inc. Led by Jack A. Khattar, public since 2012-05-01.
Snapshot as of May 15, 2026.
- Spot Price
- $49.35
- Total OI
- 1.8K